Pharma-Bio Serv (PBSV) Total Current Liabilities (2010 - 2026)

Pharma-Bio Serv's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $1.0 million for Q2 2026.

• Total Current Liabilities for Q2 2026 came in at $1.0 million, down 41.29% year-over-year; the trailing twelve-month figure through Apr 2026 was $1.0 million (down 41.29% YoY), and the FY2025 annual result was $1.7 million, down 7.86% from the prior year.
• Total Current Liabilities came in at $1.0 million for Q2 2026 at Pharma-Bio Serv, down from $3.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $3.7 million in Q1 2024 to a low of $1.0 million in Q2 2026.
• A 5-year average of $2.2 million and a median of $2.2 million in 2022 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities slumped 58.05% in 2022 and soared 87.53% in 2024, its largest moves.
• Over 5 years, Total Current Liabilities stood at $2.1 million in 2022, then advanced by 2.18% to $2.2 million in 2023, then declined by 12.37% to $1.9 million in 2024, then declined by 7.86% to $1.7 million in 2025, then slumped by 39.89% to $1.0 million in 2026.
• The last three Total Current Liabilities figures came in at $1.0 million (Q2 2026), $3.3 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.